Project Grant P20DK140417
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $462,923 to Albany Medical College to develop new mouse models of andropause (age-related decline in male sex hormones) for Alzheimer's disease and related dementia (ADRD) research. The primary goals are to: Determine the natural time course of endocrine aging in wild-type mice and mouse models of ADRD (Aim 1). Model endocrine aging in male mice via gonadectomy and gradual androgen...
- This Project Grant award of $1,616,406 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the development of a new high diversity outbred mouse population, the Wild Mouse Diversity Panel (WMDP), to enhance precision mapping and systems genetics research. The project aims to establish the WMDP as a community resource by creating novel wild-derived inbred mouse strains from a single subspecies (Mus musculus domesticus) to minimize genetic...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $203,676 to the Mayo Clinic to conduct research aimed at better understanding patient priorities and the impact of cost on surgical preference for the treatment of benign prostatic hyperplasia (BPH). The key objectives of the project are to: 1) identify the perioperative factors most...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,283,334.00 to the Morehouse School of Medicine (MSM) to develop and validate a progressive mouse model for Traumatic Brain Injury-related Alzheimer's Disease and Related Dementias (TBI-ADRD). The project aims to systematically screen mouse strains and TBI injury types to identify the optimal model for recapitulating key neuropathological, neurobiochemical, and neurocognitive features of human...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of a novel method to quantify vaginal secretion in small animals like mice. The $435,875 award, spanning from September 2025 to August 2027, will enable researchers at Indiana University to test whether mice can serve as a research model for studying various...
- The federal Project Grant award titled "ONE CELL, ONE CANCER: A NOVEL GENETIC APPROACH TO MOUSE MODELS OF HUMAN CANCER INITIATION" is being provided by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the University of Utah for a total of $154,000.00. The project aims to develop a novel dual-recombinase system, termed "FLP-OUT," to create more accurate mouse models of pancreatic ductal adenocarcinoma (PDAC) that better reflect the single-cell...
- This Project Grant award for $399,187 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support Virginia Commonwealth University's research to develop novel genetically engineered mouse models to study the development of marginal zone lymphomas (MZL). The research aims to 1) investigate the impact of activation of the PI3K/AKT/mTOR pathway on MZL development, and 2) determine optimal drug combinations for targeting this pathway in MZL. This work seeks to establish...
- This Project Grant award from the National Science Foundation (NSF) Office of Integrative Activities (CFDA 47.083) provides $914,016 to Clark Atlanta University, a private historically Black university, to conduct research on the developmental regulation of the WDR77 protein and its role in coordinating prostate growth and differentiation during puberty and young adulthood. The research aims to determine how changing androgen (male hormone) levels affect prostate development, including...
- This $414,781 Project Grant awarded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support research to investigate the effects of pelvic radiotherapy on the urinary microbiome and its potential as a biomarker for radiation cystitis in prostate cancer patients. The primary awardee, the University of Rochester, will use banked urine samples from a clinical study, as well as a preclinical mouse model, to test hypotheses that: 1) radiotherapy alters the microbial...
- This $844,954 Project Grant awarded by the National Institutes of Health (NIH) Office of the Director supports the development of "genomically rewritten and tailored humanized mouse models for various organ disorders" at New York University (NYU) School of Medicine. The project leverages advanced DNA technology to create mouse models that accurately reflect human disease susceptibility and pathology, enabling testing of novel therapies like gene editing and oligonucleotide...
VALIDATING MOUSE MODELS OF PROSTATIC HYPERPLASIA - OVERALL: SUMMARY THIS P20 FORWARD CENTER WILL SUPPORT A PROJECT CONCEIVED AND EXECUTED BY THREE EARLY STAGE INVESTIGATORS (ESIS) TO ADDRESS A PROBLEM THAT IS IMPORTANT TO THE FIELD OF BENIGN PROSTATE RESEARCH AND TO OTHER FIELDS MORE BROADLY: THE RELEVANCE OF SPECIFIC GENETICALLY ENGINEERED MOUSE MODELS TO HUMAN DISEASE. THE NEED FOR ANIMAL MODELS IN BIOMEDICAL RESEARCH AND THE UTILITY OF MICE, SPECIFICALLY, IS WELL RECOGNIZED AND ACCEPTED. A NUMBER OF MOUSE MODELS THAT PURPORT TO REPRESENT THIS DISEASE HAVE BEEN GENERATED. IT IS WELL RECOGNIZED IN THE FIELD THAT NONE OF THESE IS A GOOD OVERALL REPRESENTATION OF THE HUMAN CONDITION. AS SUCH, CRITICISM OF MODELS IS A COMMON ISSUE IN GRANT AND PAPER REVIEW. THIS IS A PROBLEM FOR ALL INVESTIGATORS IN THE FIELD AND CAN BE PARTICULARLY DAMAGING TO ESIS WHO DO NOT HAVE RESOURCES TO GENERATE DATA FROM MULTIPLE LINES. THE CENTER WILL BRING TOGETHER TWO BIOLOGISTS (DRS. POPOVICS AND VICKMAN) WITH COMPLEMENTART SKILL SETS AND AN INTEREST IN BPH, , CONTRIBUTING EXPERTISE IN MOUSE MODELS AND INFLAMMATION, WITH A BIOINFORMATICIAN (DR. LANMAN) TO DEVELOP NEW APPROACHES TO CORRELATE TRANSCRIPTOMIC DATA FROM MICE WITH EXISTING HUMAN BPH DATASETS TO ESTABLISH A REFERENCE DTABASE ENCOMPASSING SIMILARITIES AND DIFFERENCES BETWEEN INDIVIDUAL MOUSE MODELS AND SALIENT ASPECTS OF HUMAN DISEASES. SUCCESSFUL DEVELOPMENT OF THESE METHODS WILL ALLOW BROAD APPLICATION OF THE APPROACH ACROSS A RANGE OF DISEASES WHERE SUCH PROBLEMS EXIST. THE PROJECT WILL ESTABLISH STANDARDS AND BENCHMARKS FOR COMPARING MOUSE MODELS TO HUMAN BPH AND IDENTIFYING COMMONALITIES AND DISPARITIES BETWEEN THE TWO. THIS WILL FACILITATE THE SELECTION OF THE BEST MODELS AND WILL ENCOURAGE SIMILAR CHARACTERIZATION AND COMPARISON OF OTHER MODELS IN THE FIELD. THE DATA WILL BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY, AS A COLLECTION IN THE CELLXGENE PORTAL AND AS AN RSHINY APPLICATION. CONSISTENT WITH THE STATED GOALS OF THE RFA THE ADMINISTRATIVE CORE AND ITS DIRECTOR (THE PI, DR. HAYWARD) WILL SUPPORT THE PROJECT AND SPECIFICALLY WILL PROVIDE ACCESS TO RESOURCES AND EXPERTISE TO ASSIST THE THREE ESIS IN THE DEVELOPMENT OF NEW FUNDING PROPOSALS DERIVATIVE FROM THE DATA GENERATED HERE. THE ADMINISTRATIVE CORE WILL ALSO OVERSEE THE FISCAL AND REGULATORY ASPECTS OF THE CENTER AND WILL PROVIDE MECHANISMS FOR REGULAR CONTACTS BETWEEN THE PROJECT INVESTIGATORS AND THE BROADER RESEARCH COMMUNITY, IN PARTICULAR WITH PAST AND PRESENT CAIRIBU MEMBERS, FOSTERING OPPORTUNITIES TO PRESENT DATA AND FURTHERING CAREER OPPORTUNITIES. THE ADMINSTRATIVE CORE WILL ALSO COORDINATE WITH EXPERTS IN THE FIELD TO SUPPORT THE DEVELOPMENT AND SUBMISSION OF NEW GRANT PROPOSALS FROM THE ESIS. THE IMMEDIATE GOAL OF THIS CENTER IS TO SUPPORT THE DEVELOPMENT OF DATA THAT WILL CONTRIBUTE TO THE CAREER DEVELOPMENT AND FUNDING SUCCESS OF THREE EARLY STAGE INVESTIGATORS IN THE FIELD OF BENIGN UROLOGIC RESEARCH, BRING NEW IDEAS AND RETAIN EXPERTISE IN THE FIELD. THE LONG-TERM GOAL IS FOR THE ESIS TO ACHIEVE SIGNIFICANT INDEPENDENT CAREERS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $388.0k | 4/18/25 | ||
| Not listed | $428.0k | 7/26/24 | ||
| Not listed | $428.0k | 7/26/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
EH23231S2S | Old Dominion University Research Foundation | Project Grant P20DK140417 | $110.8k | 8/1/24 | |
EH23231S1S | Purdue University | Project Grant P20DK140417 | $80.7k | 8/1/24 |